Gilead to license generic lenacapavir for HIV prophylaxis in 120 lower income countries Post date 7 October 2024 ← Hearing stories of domestic abuse of female NHS doctors paves way to receive stories of women survivors of violence with empathy → Researchers hail use of anonymised GP data to drive diagnostics and treatment